Therapeutic Nuclear Medicines Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Therapeutic Nuclear Medicines Market contains market size and forecasts of Therapeutic Nuclear Medicines in global, including the following market information:
Global Therapeutic Nuclear Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Therapeutic Nuclear Medicines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Therapeutic Nuclear Medicines companies in 2021 (%)
The global Therapeutic Nuclear Medicines market was valued at 1719.4 million in 2021 and is projected to reach US$ 5230.4 million by 2028, at a CAGR of 17.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus and Acrotech Biopharma., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Nuclear Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Nuclear Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Type, 2021 (%)
Radium-223
Lutetium-177
Iodine-131
Other
Global Therapeutic Nuclear Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Application, 2021 (%)
Thyroid
Bone Metastasis
Lymphoma
Other
Global Therapeutic Nuclear Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Nuclear Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Therapeutic Nuclear Medicines revenues share in global market, 2021 (%)
Key companies Therapeutic Nuclear Medicines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Therapeutic Nuclear Medicines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes